Abiomed (NASDAQ:ABMD) is a medical device company based in Danvers, Massachusetts specializing in heart pumps for a high risk heart surgery called Percutaneous Coronary Intervention ((PCI)). We believe the company's revolutionary Impella line of heart pump products will continue to revolutionize the space due to attractive product features such as extreme reduction in risk during surgery, ease of use by doctors, and others we will touch upon further. Abiomed is the only device of its kind but has only currently penetrated a small percentage of its current addressable market. Their relative infancy in